Shell Asset Management CO Adma Biologics, Inc. Transaction History
Shell Asset Management CO
- $2.9 Billion
- Q2 2025
A detailed history of Shell Asset Management CO transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Shell Asset Management CO holds 17,663 shares of ADMA stock, worth $270,067. This represents 0.01% of its overall portfolio holdings.
Number of Shares
17,663
Previous 20,807
15.11%
Holding current value
$270,067
Previous $413,000
22.03%
% of portfolio
0.01%
Previous 0.02%
Shares
6 transactions
Others Institutions Holding ADMA
# of Institutions
398Shares Held
190MCall Options Held
2.08MPut Options Held
1.56M-
Vanguard Group Inc Valley Forge, PA21.4MShares$327 Million0.01% of portfolio
-
Black Rock Inc. New York, NY18.6MShares$285 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA12.8MShares$196 Million0.04% of portfolio
-
State Street Corp Boston, MA12.1MShares$185 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.91MShares$90.4 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...